Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Atherosclerosis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kubota Y, London SJ, Cushman M, et al. "Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study." J Thromb Haemost. 2016;14(12):2394-2401.
Kubota Y, McAdams-DeMarco M. "Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study." Thromb Res. 2016;144:144-8.
Kubota Y, Alonso A, Shah AM, Chen LYee. "Television Watching as Sedentary Behavior and Atrial Fibrillation: The Atherosclerosis Risk in Communities Study." J Phys Act Health. 2018;15(12):895-899.
Kubota Y, Chen LYee, Whitsel EA. "Heart rate variability and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study." Ann Epidemiol. 2017;27(10):619-625.e2.
Kubota Y, Cushman M, Zakai N, Rosamond WD. "TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study." J Thromb Thrombolysis. 2018;45(3):353-359.
Kubota Y, Alonso A, Heckbert SR, Norby FL. "Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis." Heart Lung Circ. 2019;28(4):615-622.
Kubota Y, Alonso A. "β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study." Thromb Res. 2017;155:116-120.
Kucharska-Newton AMaria, Heiss G, Ni H, Stearns SC, Puccinelli-Ortega N, Wruck LM. "Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study." J Card Fail. 2016;22(1):48-55.
Kucharska-Newton AMaria, Griswold M, Yao ZHoward, et al. "Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2017;6(3).
Kucharska-Newton AMaria, Palta P, Burgard S, et al. "Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort." J Gerontol A Biol Sci Med Sci. 2017;72(3):382-388.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Kucharska-Newton AM, Rosamond WD, Schroeder JC, McNeill A M, Coresh J, Folsom AR. "HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study." Lung Cancer. 2008;61(3):292-300.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study." Acta Diabetol. 2010;47 Suppl 1:161-8.
Kummer AE, Grams M, Lutsey PL, et al. "Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(11):2023-9.
Kytömaa S, Hegde S, Claggett B, et al. "Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study." JAMA Cardiol. 2019;4(4):363-369.
L
Lacy ME, Wellenius GA, Carnethon MR, et al. "Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study." Diabetes Care. 2016;39(2):285-91.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Lazo M, Halushka MK, Shen L, et al. "Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study." Am Heart J. 2015;170(5):961-7.
Lee AK, Lee CJ, Huang ES, Sharrett ARichey, Coresh JJ. "Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2017;40(12):1661-1667.
Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC. "Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study." Clin Pharmacol Ther. 2008;83(1):52-60.
Li D, Misialek JR, Jack CR, et al. "Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS)." Int J Mol Sci. 2019;20(7).
Li D, Misialek JR, Jing M, et al. "Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study." Am J Clin Nutr. 2020;111(6):1252-1258.
Li D, Misialek JR, Huang F, Windham GB, Yu F. "Independent Association of Plasma Hydroxysphingomyelins With Physical Function in the Atherosclerosis Risk in Communities (ARIC) Study." J Gerontol A Biol Sci Med Sci. 2018;73(8):1103-1110.
Li AH, Morrison AC, Kovar C, et al. "Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease." Nat Genet. 2015;47(6):640-2.
Li M, Carey J, Cristiano S, et al. "Genome-Wide Association of Copy Number Polymorphisms and Kidney Function." PLoS One. 2017;12(1):e0170815.
Liang M, McEvoy JWilliam, Chen Y, Sharrett ARichey. "Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease." Diabetes Care. 2016;39(10):1752-9.
Liew G, Campbell S, Klein R, et al. "Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study." Ophthalmology. 2011;118(8):1612-8.
Lin H, Mares JA, Lamonte MJ, et al. "Association between Dietary Xanthophyll (Lutein and Zeaxanthin) Intake and Early Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study." Ophthalmic Epidemiol. 2017;24(5):311-322.
Loehr LR, Rosamond WD, Poole C, et al. "The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study." Am J Epidemiol. 2010;172(7):781-9.
Loehr LR, Rosamond WD, Poole C, et al. "Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study." Circ Heart Fail. 2009;2(1):18-24.
Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. "Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)." Am J Cardiol. 2008;101(7):1016-22.
Loomis SJ, Tin A, Coresh JJ, et al. "Heritability analysis of nontraditional glycemic biomarkers in the Atherosclerosis Risk in Communities Study." Genet Epidemiol. 2019;43(7):776-785.
Loomis SJ, Li M, Maruthur NM, et al. "Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study." Diabetes. 2018;67(8):1684-1696.
Loomis SJ, Köttgen A, Li M, et al. "Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study." Sci Rep. 2019;9(1):5941.
Luft VC, Duncan BB, Schmidt MI, et al. "Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study." Diabet Med. 2016;33(10):1392-8.
Luft VC, Pereira M, Pankow JS, Ballantyne CM, Couper DJ, Heiss G. "Retinol binding protein 4 and incident diabetes--the Atherosclerosis Risk in Communities Study (ARIC Study)." Rev Bras Epidemiol. 2013;16(2):388-97.
Luft VC, Schmidt M I, Pankow JS, et al. "Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2010;33(5):1109-11.
Lusk CM, Dyson G, Clark AG, et al. "Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study." Hum Genet. 2014;133(9):1105-16.
Lutsey PL, Bengtson LGS, Punjabi NM, et al. "Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study." Sleep. 2016;39(2):309-16.
Lutsey PL, Norby FL, Gottesman RF, et al. "Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)." PLoS One. 2016;11(7):e0158758.
Lutsey PL, Michos ED, Misialek JR, et al. "Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study." JACC Heart Fail. 2015;3(5):347-356.
Lutsey PL, Rooney MR, Folsom AR, Michos ED, Alonso A. "Markers of vitamin D metabolism and incidence of clinically diagnosed abdominal aortic aneurysm: The Atherosclerosis Risk in Communities Study." Vasc Med. 2018;23(3):253-260.
Lutsey PL, Eckfeldt JH, Ogagarue ER, Folsom AR, Michos ED. "The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)." Clin Chim Acta. 2015;442:75-81.
Lutsey PL, Alonso A, Michos ED, Loehr LR, Astor BC, Coresh JJ. "Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2014;100(3):756-64.
Lutsey PL, Rasmussen-Torvik LJ, Pankow JS, et al. "Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study." Circ Cardiovasc Genet. 2012;5(1):73-80.
Lutsey PL, Chen N, Mirabelli MC, et al. "Impaired Lung Function, Lung Disease, and Risk of Incident Dementia." Am J Respir Crit Care Med. 2019;199(11):1385-1396.
Lutsey PL, Misialek JR, Mosley TH, et al. "Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study." Alzheimers Dement. 2018;14(2):157-166.
M
Ma Y, Tucker KL, Smith CE, et al. "Lipoprotein lipase variants interact with polyunsaturated fatty acids for obesity traits in women: replication in two populations." Nutr Metab Cardiovasc Dis. 2014;24(12):1323-9.
Madan N, Lee AK, Matsushita K, Hoogeveen RC, Ballantyne CM, Selvin E. "Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2019;124(2):245-252.
Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LYee, Loehr LR. "Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study." JAMA Cardiol. 2016;1(4):433-41.
Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. "P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study." Obesity (Silver Spring). 2012;20(3):666-72.
Maheshwari A, Norby FL, Soliman EZ, et al. "Abnormal P-Wave Axis and Ischemic Stroke: The ARIC Study (Atherosclerosis Risk In Communities)." Stroke. 2017;48(8):2060-2065.
Maheshwari A, Norby FL, Soliman EZ, Adabag S, Whitsel EA, Alonso A. "Low Heart Rate Variability in a 2-Minute Electrocardiogram Recording Is Associated with an Increased Risk of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities Study." PLoS One. 2016;11(8):e0161648.
Mamo SK, Reed NS, Sharrett ARichey, et al. "Relationship Between Domain-Specific Cognitive Function and Speech-in-Noise Performance in Older Adults: The Atherosclerosis Risk in Communities Hearing Pilot Study." Am J Audiol. 2019;28(4):1006-1014.
Martin SS, Daya N, Lutsey PL, et al. "Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study." J Clin Endocrinol Metab. 2017;102(9):3306-3315.
Matsushita K, Kwak L, Hyun N, et al. "Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance." PLoS One. 2017;12(8):e0181373.
Matsushita K, Blecker S, Pazin-Filho A, et al. "The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study." Diabetes. 2010;59(8):2020-6.
McAdams MA, Maynard JW, Baer AN, et al. "Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts." J Rheumatol. 2011;38(1):135-41.
McAdams-Demarco MA, Maynard JW, Coresh JJ. "Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study." Arthritis Res Ther. 2012;14(4):R193.
M McDoom M, Palta P, Vart P, Juraschek SP, Kucharska-Newton AMaria, Diez Roux AV. "Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study." J Hypertens. 2018;36(6):1382-1390.
McEvoy JW, Lazo M, Chen Y, et al. "Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study." Int J Cardiol. 2015;187:651-7.
McKibben RA, Zhao D, Lutsey PL, Schneider ALC, Guallar E, Mosley TH. "Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study." J Clin Endocrinol Metab. 2016;101(1):33-43.
Mellen PB, Bleyer AJ, Erlinger TP, et al. "Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study." Hypertension. 2006;48(6):1037-42.
Mertens AJ, Sweeney C, Shahar E, Rosamond WD, Folsom AR. "Physical activity and breast cancer incidence in middle-aged women: a prospective cohort study." Breast Cancer Res Treat. 2006;97(2):209-14.
Meyer ML, Soliman EZ, Wruck LM, et al. "Repeatability of ectopic beats from 48-hr ambulatory electrocardiography: The Atherosclerosis Risk in Communities (ARIC) Study." Ann Noninvasive Electrocardiol. 2017;22(4).
Meyer ML, Tanaka H, Palta P, Cheng S, Gouskova N, Aguilar D. "Correlates of Segmental Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Hypertens. 2016;29(1):114-22.
Meyer TE, Boerwinkle E, Morrison AC, et al. "Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study." Cancer Epidemiol Biomarkers Prev. 2010;19(2):558-65.
Meyer ML, Palta P, Tanaka H, et al. "Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS)." J Alzheimers Dis. 2017;57(1):195-204.
Michos ED, Carson KA, Schneider ALC, et al. "Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study." JAMA Neurol. 2014;71(7):863-71.
Miedema MD, Norby FL, Blaha MJ, Virani SS, Coresh JJ, Ballantyne CM. "Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort." JAMA Intern Med. 2015;175(1):138-40.
Miedema MD, Norby FL, Blaha MJ, Virani SS, Coresh JJ, Ballantyne CM. "Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study." Hypertension. 2015;66(3):474-80.
Millen AE, Nie J, Sahli MW, et al. "Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study." J Nutr Health Aging. 2017;21(7):772-780.
Millen AE, Nie J, Mares JA, et al. "Serum 25-Hydroxyvitamin D Concentrations and Incidence of Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study." Invest Ophthalmol Vis Sci. 2019;60(5):1362-1371.
Mirabelli MC, London SJ, Charles LE, Pompeii LA. "Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study." J Occup Environ Med. 2012;54(2):157-65.
Mirabelli MC, London SJ, Charles LE, Pompeii LA. "Occupation and three-year incidence of respiratory symptoms and lung function decline: the ARIC Study." Respir Res. 2012;13:24.
Misialek JR, Norby FL, Lutsey PL, et al. "Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study." Circ J. 2013;77(2):323-9.
Misialek JR, Bekwelem W, Chen LYee, et al. "Association of White Blood Cell Count and Differential with the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study." PLoS One. 2015;10(8):e0136219.
Moazzami K, Shao IYuefan, Chen LYee, et al. "Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS])." Am J Cardiol. 2020;125(2):222-228.
Monda KL, Ballantyne CM, North KE. "Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study." J Lipid Res. 2009;50(8):1685-91.
Mondul AM, Joshu CE, Barber JR, et al. "Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study." Cancer Prev Res (Phila). 2018;11(12):779-788.

Pages